胶质瘤
- 工具分子
- 获批药物
- Everolimus
- Bevacizumab
- Belzutifan
- Carmustine
- Naxitamab
- Dabrafenib Mesylate
- Eflornithine hydrochloride hydrate
- Lomustine
- Trametinib DMSO solvate
- TMZ
- 化疗
-
- 单药
- TMZ
- Carmustine
- 靶向疗法 (A)
- 靶向疗法 (B)
- 近期活跃药物
- Mirdametinib
- Tovorafenib
- Panobinostat
- Paxalisib
- Retinoic acid
- Vorasidenib
- Olutasidenib
- BDTX-1535
- Pterostilbene
- DS-1001b
- 5-Aminolevulinic acid HCl
- 胶质瘤干细胞
-
- PLK1 [1]
- SBE 13 HCl
-
- PIN1 [1]
- Sulfopin
-
- BRG1/BRM [2]
- BRM/BRG1 ATP Inhibitor-1
- PFI-3
- AU-15330
-
- CARM1 [2]
- TP-064
-
- METTL3 [3]
- UZH2
-
- ADAM10 [4]
- GI254023X
-
- ADAM17 [4]
- TAPI-1
- Batimastat
- KP-457
- GI254023X
- 恶性突触 [5]
-
- Pan-TrK抑制剂
- Entrectinib
- Larotrectinib
-
- AMAPR抑制剂
- NBQX
- Kynurenic acid
- DNQX
- Capric acid
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Anti-cancer Metabolism Compound Library
- Cambridge Cancer Compound Library
- Small Molecule Immuno-Oncology Compound Library
- Tyrosine Kinase Inhibitor Library
- Angiogenesis Related compound Library
- MAPK Inhibitor Library
- PI3K/Akt Inhibitor Library
